202 related articles for article (PubMed ID: 17962085)
1. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
Balogh L; Nigavekar SS; Nair BM; Lesniak W; Zhang C; Sung LY; Kariapper MS; El-Jawahri A; Llanes M; Bolton B; Mamou F; Tan W; Hutson A; Minc L; Khan MK
Nanomedicine; 2007 Dec; 3(4):281-96. PubMed ID: 17962085
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
Sonavane G; Tomoda K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):274-80. PubMed ID: 18722754
[TBL] [Abstract][Full Text] [Related]
3. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles.
He X; Nie H; Wang K; Tan W; Wu X; Zhang P
Anal Chem; 2008 Dec; 80(24):9597-603. PubMed ID: 19007246
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography.
Zhang Q; Iwakuma N; Sharma P; Moudgil BM; Wu C; McNeill J; Jiang H; Grobmyer SR
Nanotechnology; 2009 Sep; 20(39):395102. PubMed ID: 19726840
[TBL] [Abstract][Full Text] [Related]
5. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
De Jong WH; Hagens WI; Krystek P; Burger MC; Sips AJ; Geertsma RE
Biomaterials; 2008 Apr; 29(12):1912-9. PubMed ID: 18242692
[TBL] [Abstract][Full Text] [Related]
6. In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges.
Kasturirangan V; Nair BM; Kariapper MT; Lesniak WG; Tan W; Bizimungu R; Kanter P; Toth K; Buitrago S; Rustum YM; Hutson A; Balogh LP; Khan MK
Nanotoxicology; 2013 Jun; 7(4):441-51. PubMed ID: 22394369
[TBL] [Abstract][Full Text] [Related]
7. Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings.
Faure AC; Dufort S; Josserand V; Perriat P; Coll JL; Roux S; Tillement O
Small; 2009 Nov; 5(22):2565-75. PubMed ID: 19768700
[TBL] [Abstract][Full Text] [Related]
8. Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges.
Xu F; Yuan Y; Shan X; Liu C; Tao X; Sheng Y; Zhou H
Int J Pharm; 2009 Jul; 377(1-2):199-206. PubMed ID: 19454305
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies.
Khlebtsov N; Dykman L
Chem Soc Rev; 2011 Mar; 40(3):1647-71. PubMed ID: 21082078
[TBL] [Abstract][Full Text] [Related]
10. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study.
Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ
J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
12. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.
Morais T; Soares ME; Duarte JA; Soares L; Maia S; Gomes P; Pereira E; Fraga S; Carmo H; Bastos Mde L
Eur J Pharm Biopharm; 2012 Jan; 80(1):185-93. PubMed ID: 21946301
[TBL] [Abstract][Full Text] [Related]
13. Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices.
Shi X; Majoros IJ; Baker JR
Mol Pharm; 2005; 2(4):278-94. PubMed ID: 16053331
[TBL] [Abstract][Full Text] [Related]
14. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
Shan X; Liu C; Yuan Y; Xu F; Tao X; Sheng Y; Zhou H
Colloids Surf B Biointerfaces; 2009 Sep; 72(2):303-11. PubMed ID: 19450955
[TBL] [Abstract][Full Text] [Related]
15. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy.
Zhang XD; Wu D; Shen X; Chen J; Sun YM; Liu PX; Liang XJ
Biomaterials; 2012 Sep; 33(27):6408-19. PubMed ID: 22681980
[TBL] [Abstract][Full Text] [Related]
16. Size-dependent cytotoxicity of gold nanoparticles.
Pan Y; Neuss S; Leifert A; Fischler M; Wen F; Simon U; Schmid G; Brandau W; Jahnen-Dechent W
Small; 2007 Nov; 3(11):1941-9. PubMed ID: 17963284
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery.
Bergen JM; von Recum HA; Goodman TT; Massey AP; Pun SH
Macromol Biosci; 2006 Jul; 6(7):506-16. PubMed ID: 16921538
[TBL] [Abstract][Full Text] [Related]
19. Intracellular uptake, transport, and processing of gold nanostructures.
Chithrani DB
Mol Membr Biol; 2010 Oct; 27(7):299-311. PubMed ID: 20929337
[TBL] [Abstract][Full Text] [Related]
20. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice.
Akiyama Y; Mori T; Katayama Y; Niidome T
J Control Release; 2009 Oct; 139(1):81-4. PubMed ID: 19538994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
